학술논문
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Document Type
Article
Author
Source
In Journal of Thoracic Oncology May 2019 14(5):867-875
Subject
Language
ISSN
1556-0864